Physician profile
Keith Michael Nord
NPI 1649624677
$84,161.10
in general payments reported to CMS, 2019-2025
19 companies · $26K in 2025
The $26K reported for 2025 was more than what 96% of Surgery of The Hand (Surgery) providers received nationally (typical 2025 total: $285).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13K · 2022: $3,079 · 2023: $37K · 2024: $5,494 · 2025: $26K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $37K · Consulting Fee: $27K · Travel and Lodging: $2,496 · Food and Beverage: $2,259.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $36,510.55 |
| Consulting Fee | $26,755.40 |
| Travel and Lodging | $2,495.70 |
| Food and Beverage | $2,258.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $36,510.55 | 2023 | Arthrex |
| Sonex Health, INC. | $31,128.61 | 2022-2025 | Sx-One Microknife |
| Acumed LLC | $10,000.00 | 2021 | |
| Peerless Surgical INC. | $2,430.89 | 2022 | |
| Axogen | $1,524.18 | 2021-2022 | |
| Midsouth Orthopedics INC. | $1,204.37 | 2021 | |
| Medical Device Business Services, INC. | $349.99 | 2021 | |
| Endo Pharmaceuticals INC. | $231.66 | 2021-2024 | Xiaflex |
| Depuy Synthes Sales INC. | $149.24 | 2021-2022 | |
| Skeletal Dynamics INC | $139.18 | 2022-2024 | Geminus, Implate, Ijs |
| Osteomed LLC | $121.83 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $88.75 | 2024-2025 | |
| Endo USA, INC. | $85.49 | 2024-2025 | Xiaflex |
| Djo, LLC | $69.92 | 2023-2025 | Cmf |
| Pacira Pharmaceuticals Incorporated | $64.53 | 2023-2024 | Zilretta, Exparel, Iovera |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.50 | 2023 | Bridion |
| Fidia Pharma USA INC. | $19.30 | 2024 | Hyalgan, Triluron, Hymovis |
| Medartis INC. | $12.82 | 2021 | |
| Trimed, INC. | $10.29 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keith Nord listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.